NeurosciencebioRxivPreprint
Nicotinamide mononucleotide treatment increases NAD+ levels in an iPSC Model of Parkinsons Disease
Brett Fulleylove-Krause, Samantha L. Sison, Allison D. Ebert
The paper tests if nicotinamide mononucleotide treatment increases NAD+ levels and sirtuin activity in Parkinson's disease stem cell-derived dopaminergic neurons.
2 citations